Bridge PTS

What Bridge PTS does

BRIDGE PTS (Preclinical Testing Services), Inc. is a privately held contract research organization founded in 2006 by Dr. Paul Attar and headquartered in San Antonio, Texas. The company delivers specialized preclinical testing services using predictive in vivo animal models for wound healing, biofilm-related infections, and medical device evaluation. Its primary customers are pharmaceutical and medical device manufacturers seeking preclinical efficacy data for clinical-trial de-risking and product marketing, with secondary segments in academic and government research (including NIH and DoD-funded studies) and regulatory/compliance-driven testing programs.

The company's technical differentiation rests on a portfolio of proprietary animal models — most notably a porcine chronic wound healing model that keeps wounds open for more than 70 days using chemical crosslinkers, an FDA-recommended porcine infected wound model, and a comprehensive suite of biofilm infection models (subcutaneous implant, transcutaneous, peritoneal, peri-joint, and ventilator-assisted pneumonia). It also operates specialized surgical models for breast implants, dental implants, and rabbit vaginal mucosal irritation. In April 2025, BRIDGE PTS relocated from the Brooks City Base facility (used 2006-2025) to a newly constructed, purpose-built 14,000+ sq. ft. vivarium near San Antonio International Airport, featuring four 350 sq. ft. surgical suites and housing capacity for 50-100 mature minipigs and 60+ additional large animals.

Revenue is generated through project-based contracts structured around a seven-step engagement process from initial consultation through IACUC approval and study initiation. The go-to-market motion is enterprise direct sales supplemented by conference presence (SAWC, TERMIS, American Burn Association), referrals, and content marketing via the company blog. The company holds AAALAC accreditation (since November 2017), GLP compliance, a USDA research license (74-R-0199), OLAW Domestic Assurance (A4672-01), and a DEA license (RB 0343905), which together serve as a regulatory moat for serving pharmaceutical and federally funded customers.

Name

Bridge PTS

Legal name

BRIDGE PTS, Inc.

Website

https://bridgepts.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

1–10 employees

Short description

Bridge PTS is a privately held San Antonio-based contract research organization providing preclinical in vivo testing services for wound healing, biofilm infections, and medical devices, serving pharmaceutical, medical device, and academic/government customers through AAALAC-accredited, GLP-compliant animal studies.

Ownership category

akta.pro rank

Product category

Preclinical Contract Research Services

NAICS

Veterinary Services (541940), Veterinary Services (54194)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Research, Trials & Translational Services (Veterinary Regenerative) (HLAMANAL)

Keywords

• Preclinical contract research
• Wound healing testing
• Biofilm infection models
• Antimicrobial efficacy testing
• Medical device evaluation

Headquarters

HQ city

San Antonio

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Contract Preclinical Research Services: BRIDGE PTS provides contract preclinical testing services including wound healing studies, biofilm/infection models, and medical device safety testing. Revenue is generated through project-based contracts for study design, execution, and reporting. The company follows a structured project proposal process with non-binding quotes, initial invoices, and detailed study protocols.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Bridge PTS provides contract preclinical research services using predictive in vivo animal models (porcine, rodent, rabbit, goat, sheep) for wound healing, biofilm-related infections, and medical device safety/efficacy evaluation. Services include study design, surgical execution, in vitro microbiology, histology, and reporting under GLP/AAALAC-compliant protocols to help pharmaceutical, medical device, and academic/government clients de-risk products ahead of clinical trials and generate regulatory-grade data.

Product overview

Bridge PTS (Preclinical Testing Services) is a contract preclinical research organization providing specialized testing services in wound healing, infection control, and biofilm-related infections. The company operates as a service-based offering rather than a software platform, providing access to their testing capabilities through study proposals. The portfolio includes core service lines for wound healing testing (porcine, rodent, rabbit, and goat models), infection control and biofilm testing (in vitro and in vivo), and customized surgical work including surgical space rental. Specific testing models include acute and delayed wound healing, thermal injury models, debridement effectiveness, dental implantation, peri-joint infection, and various microbiology assays. The company also provides facility access for clients to conduct their own studies using Bridge PTS's surgical suites and animal housing.

Differentiator

Problem solved

Functional benefit

Products and services

• Wound Healing Testing Services

Quantifiable outcome

• 75-80% predictive of more complicated animal models using the rat subcutaneous implant model for antimicrobial screening
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered minor and core.

• UIW School of Osteopathic MedicineminorStrategic or Co-development PartnerAcademic collaborator for research and development initiatives in wound healing and related fields.
• Wyle Altitude Research Chambers (KBR)minorStrategic or Co-development PartnerResearch collaboration partner specializing in altitude research and related testing capabilities.
• Alamo BioCenterminorStrategic or Co-development PartnerLocal biotechnology research center collaboration for shared research initiatives.
• Montana State University - Center for Biofilm EngineeringcoreStrategic or Co-development PartnerKey academic research partner specializing in biofilm engineering, which is central to BRIDGE PTS's core competency in biofilm-related infection models.
• US Army – Tri-Services Veterinary Group on Fort Sam HoustoncoreStrategic or Co-development PartnerGovernment research partner providing collaboration for military-related wound healing and infection control research. BRIDGE PTS has licensing to work with federal grants including NIH and DoD funded projects.
• US Army – Institute for Surgical Research at Brook Army Medical CentercoreStrategic or Co-development PartnerKey government research partner specializing in surgical research, supporting BRIDGE PTS's wound healing and infection control expertise.

Scale indicators5 records

Recent moves8 records

Expansion highlights4 records

Others

• North American Science Associates (NAMSA, already listed): (Omitted to avoid duplication; NAMSA is already included as the most direct peer.)

Direct peers

• Toxikon: Toxikon is a preclinical contract research organization specializing in medical device, pharmaceutical, and biologics safety testing, including biocompatibility and animal studies. Its service mix in extractables/leachables and animal-model safety work directly parallels Bridge PTS's regulated in vivo testing business.
• MB Research Labs: MB Research Labs is an independent preclinical CRO offering in vitro and in vivo safety, irritation, sensitization, and efficacy studies. Its generalist preclinical testing portfolio for medical devices and pharmaceuticals overlaps heavily with Bridge PTS's biocompatibility and wound/infection model work.
• Sinclair Research Center: Sinclair Research Center is a contract preclinical CRO offering safety, pharmacology, and efficacy studies across multiple animal models. It is comparable to Bridge PTS as a mid-sized in vivo CRO serving pharma and medical device sponsors with project-based study execution.
• NAMSA: NAMSA is a contract medical device research organization offering preclinical testing, biological safety, and sterilization services. It directly overlaps with Bridge PTS's medical-device safety testing and ISO 10993-related work, serving many of the same medical-device and combination-product clients.
• IIT Research Institute (IITRI): IITRI is a not-for-profit contract research organization providing preclinical toxicology, pharmacology, and efficacy studies in animal models. Its government-funded and pharma-sponsored in vivo research portfolio makes it a direct comparator to Bridge PTS's federally licensed preclinical work.

Broad incumbents

• Labcorp Drug Development (Covance): Labcorp's drug development arm (formerly Covance) is a full-service CRO with extensive preclinical safety and efficacy capabilities across multiple animal models. It competes with Bridge PTS for pharma-sponsored preclinical studies while offering additional clinical and central lab services.
• WuXi AppTec: WuXi AppTec is a global CRO/CDMO with preclinical safety, bioanalytical, and medical-device testing services. It overlaps with Bridge PTS in regulated preclinical work but operates at vastly greater scale and geographic reach across the U.S. and China.
• Charles River Laboratories: Charles River Laboratories is a large global CRO offering preclinical safety assessment, discovery, and research models services. It competes with Bridge PTS in regulated preclinical in vivo work but serves clients from a much broader portfolio and global footprint.
• Eurofins Scientific: Eurofins is a global testing services group with significant pharmaceutical and medical-device testing capabilities, including preclinical and microbiology work. It is comparable to Bridge PTS in the testing-services layer but competes from a much broader industry-wide platform.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/bridge-pts

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bridge PTS